All Articles

Stable's new app, StablePay, promises instant, free global USDT payments. But beyond the slick interface, can it truly disrupt the remittance market?

A new hospital designation promises safer surgical care for older adults. But what are the hidden costs for hospitals, and will it truly empower patients?

A new generation of rugged, smart coolers is pushing life-saving blood to the front lines, transforming a medical problem into a solved logistics challenge.

Titan Mining's breakthrough in graphite purity and yield isn't just a technical win; it's a crucial step to break foreign supply chain holds for EV batteries.

A new clinic in one of America's fastest-growing cities isn't just about local expansion. It's a calculated bet on a new model for orthopedic care.

A landmark contract for the JASSM missile program reveals a new reality: production, not design, is the bottleneck. Can AI-driven factories fix it?

As streaming giants chase scale, IVOX+ bets on niche culture and veteran vision. A deep dive into its strategy to empower indie creators and redefine value.

As autonomous AI agents learn to mimic apps and breach APIs in minutes, Approov rolls out a global defense network designed to stop them cold.

For the second year, RELEX is a top supply chain leader. We dive into how its agentic AI and composable platform are delivering real ROI beyond the hype.

BNY's stellar Q2 earnings are more than just numbers. They reveal a strategic pivot to a platform model, AI, and digital assets, setting a new bar.

GW RhythmX's new AI tool, RhythmX Pulse, is now on the Microsoft Marketplace, promising to turn patient conversations into real-time clinical insights for doctors.

Rabobank extends its eight-year collaboration with Expert.ai, betting on a hybrid AI approach to navigate regulatory demands and redefine automation in finance.

Beijing's new ASEAN heritage initiative is more than a cultural exchange. It's a high-stakes play using AI and creative commerce to forge deep strategic bonds.

Morningstar's 2027 London move to a landmark sustainable office is more than a relocation. It's a strategic play on UK confidence and market synergy.

As autonomous AI agents rewrite business rules, static governance is failing. A new platform from LatticeFlow AI offers a shift from paper policy to technical proof.

Ascletis Pharma announces a new once-daily oral obesity drug, aiming to match the power of injectables like Zepbound in a convenient pill form.

Metazoa's new Org Intelligence Server uses 'context engineering' to make vast Salesforce metadata digestible for AI, promising smarter admins and autonomous agents.

Rubico Inc. is selling its luxury megayacht to double down on oil tankers. A look at whether this strategic pivot can overcome a history of investor doubt.

A new bispecific antibody from Kelun-Biotech and Harbour BioMed just got a green light in China, promising quarterly doses for asthma. Is this the innovation that finally unseats the market giants?

HERVolution Therapeutics reveals a stunning link between dormant viruses in our genome and metabolic disease, opening a new frontier beyond oncology.